620987-61-3

Upstream product

• 620987-50-0 (8E)-(3S,5R,6S)-3-(2-cyanoethyl)-14-methoxy-6-methyl-1-oxo-2,3,4,5,6,7,10-heptahydrobenzo[f][12]-annulen-5-yl 4-nitrobenzoate 
• 620987-58-8 (2S,3R,5S)-5-((S)-1-Methyl-but-3-enyl)-tetrahydro-furan-2,3-diol 
• 620987-46-4 (4E)-(1R,3R)-1-((1S)-1-methylbut-3-enyl)-5-cyano-3-(6-methoxy-2-prop-2-enylphenylcarbonyloxy)pent-4-enyl 4-nitrobenzoate 
• 620987-48-6 1-[(2S)-4-cyano-2-(6-methoxy-2-prop-2-enylphenylcarbonyloxy)butyl]-(1R,2S)-2-methylpent-4-enyl 4-nitrobenzoate 
• 620987-45-3 1-((1E)-2-cyanovinyl)-(1R,3S,4S)-3-hydroxy-4-methylhept-6-enyl 6-methoxy-2-prop-2-enylbenzoate 
• 865622-40-8 1-((1Z)-2-cyanovinyl)-(1R,3S,4S)-3-hydroxy-4-methylhept-6-enyl 6-methoxy-2-prop-2-enylbenzoate 
• 865622-39-5 5-((1S)-1-methylbut-3-enyl)-(3R,5S)-2-hydroxy-oxolan-3-yl 6-methoxy-2-prop-2-enylbenzoate 
• 620987-44-2 5-((1S)-1-methylbut-3-enyl)-(3R,5S)-2-oxo-3,4,5-trihydrofuryl 6-methoxy-2-prop-2-enylbenzoate 
• 620987-42-0 7-((1S)-1-methylbut-3-enyl)-(1R,5R,7S)-3,3-dimethyl-2,4,6-trioxabicyclo[3.3.0]octane 
• 620987-43-1 5-((1S)-1-methylbut-3-enyl)-(3R,5S)-3-hydroxy-3,4,5-trihydrofuran-2-one 
• 78784-96-0 7-((1S)-1-bromoethyl)-(1R,5R,7S)-3,3-dimethyl-2,4,6-trioxabicyclo[3.3.0]octane 
• 58475-17-5 (R)-1-((3aR,5S,6aR)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)ethan-1-ol 
• 865622-38-4 5-((1S)-1-methylbut-3-enyl)-(3R,5S)-oxolane-2,3-diol 
• 865622-49-7 (1S,3R,4S)-1-(2-cyanoethyl)-4-methyl-3-(4-nitrophenylcarbonyloxy)hept-6-enyl 6-hydroxy-2-(prop-2-enyl)benzoate 

Relevant academic research and scientific papers

Formal total syntheses of the (-)-salicylihalamides A and B from D-glucose and L-rhamnose

Two formal total syntheses of the (-)-salicylihalamides, based on chiral pool approaches, are reported. D-Glucose and L-rhamnose were used to prepare advanced intermediates 23 and 54, which can be converted in three or four steps, respectively, to the tar

Enantiospecific Formal Total Syntheses of (-)-Salicylihalamides A and B from D-Glucose and L-Rhamnose

(Matrix Presented) Two formal chiral pool syntheses of the (-)-salicylihalamides A and B were achieved from commercially available 1,2,5,6-diacetone-D-glucose and L-rhamnose.